Research Scientist

M.Pharm / Ph.D ; Candidates having 3 to 8 years experience in Product development of Solid Orals, Onco OSD, Liquid Orals and Sterile formulations. Markets handled : Regulated / ROW / Domestic.

Second class PG degrees including integrated PG degrees with PhD For example M.Sc. in Chemistry, Biotechnology, Bioscience, Life sciences or equivalent or M.Tech., M.E, M.S. in Bioengineering, Biotechnology, Nanotechnology, Material Science or equivalent; M.Pharm - Pharmaceutics

Post Graduate Degree Life Sciences, including the integrated PG degrees; Experience in performing wet-lab Next Generation Sequencing and data analysis Bioinformatics essential and applicants without this experience may not be considered for interview.

postgraduate degree in Zoology, Biochemistry, Biotechnology, Life Science or a related field with the research experience after completing PG or Ph.D. research experience in molecular biology techniques and animal handling.

The candidates should mandatory have extensive experience through their PhD or other trainings in working with transplantable or inducible mouse models of cancer, and be well-versed in multi-colour flow cytometry. The candidates should be well-versed with regular laboratory techniques, which include but are not limited to western blotting, Immunohistochemistry, qPCR, etc

Post-Graduation degree, including the integrated PG degree, in any branch of Life Sciences from a recognized university with five years of post-qualification experience of working with mammalian expression, stable CHO cell line or mRNA vaccine platform and strong molecular biology experience.

M.Sc. in life sciences and other biological Sciences; To Study the protective effect of antioxidant C and E on diesel exhaust microenvironment induced testicular injury in laboratory rat. 

Boron based therapeutics against RNA viruses and associated post infection arthritis in chikungunya infection-a preclinical evaluation. First Class M.Sc. in Biochemistry, Microbiology, Biotechnology, life Sciences. OR 2nd class postgraduate with PhD. in Biochemistry, Microbiology, Biotechnology, life Sciences.

Noninvasive and in situ forming peptide-polymer hydrogel containing CPP decorated nanoparticles, photoresponsive agents with crystallin aggregates disaggregating propensity for potential cataract therapy.